25th edition Strategic Project & Portfolio Management for Pharma

The marcus evans 25^th Edition Strategic Project & Portfolio Management for Pharma conference taking place on 3-5 June, 2024 in Barcelona, Spain, will provide a unique opportunity for leading project and portfolio experts to advance their critical decision-making capabilities and further maximise the value of their portfolio from early to late-stage developments. The conference is recognised by senior project & portfolio experts to be one of the most engaging and interactive events for the Pharma industry, bringing both actionable insights through concrete case studies and panels and maximising value of the meeting with unique discussion between expert speakers and attendees.

Attending This Premier marcus evans Conference Will Enable You to:

• Level Up Your Strategic Portfolio Decision-Making With AI.
• Evaluate and Prioritise Global Drug Development Pipeline.
• Increase Value of Project and Portfolio Pipeline.
• Master your Portfolio Metrics in Clinical Development.
• External Landscaping and Opportunities Identification.
• Drive Project and Portfolio Efficiency through Effective Scenario Planning & Projects Prioritisation.

Best Practices and Case Studies from:

• Frank Berger, Head of Analytics, Global Clinical Operations, Boehringer Ingelheim, Germany
• Marc Soriano, R&D Project Portfolio and Partnership Excellence, Senior Director, Almirall
• Amit Arkad, Director R&D Project Management - mRNA Vaccines, GSK, Belgium
• Alaina Kupec, Executive Director, Portfolio Strategy & Analytics, Gilead Sciences, USA
• Giuseppe Ciavarro, Head Portfolio Effectiveness, Novartis, USA
• Irina Chublukova, Head of Product Portfolio, Polpharma Group B.V., The Netherlands

For more information please contact: Ria Kiayia at riak@marcusevanscy.com or visit the event website: https://bit.ly/3TA1Bh1